First Tracks Biotherapeutics (TRAXV) Stock Price, News & Analysis
Company Description
First Tracks Biotherapeutics (NASDAQ: TRAXV) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $782.2M, ranking #3,170 among all listed U.S. companies by market cap.
This page collects what Stock Titan holds for TRAXV, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
TRAXV Rankings
Latest News
SEC Filings
First Tracks Biotherapeutics has filed 5 recent SEC filings, including 3 Form 4, 1 Form 10-Q, 1 Form 8-K. The most recent filing was submitted on May 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TRAXV SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
TRAXV Company Profile & Sector Positioning
First Tracks Biotherapeutics (TRAXV) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.